BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mizusawa M, Small BA, Hsu YJ, Sharara SL, Advic E, Kauffman C, Milstone AM, Feldman L, Pahwa AK, Trivedi JB, Landrum MB, Maragakis LL, Carroll KC, Cosgrove SE, Rock C. Prescriber Behavior in Clostridioides difficile Testing: A 3-Hospital Diagnostic Stewardship Intervention. Clin Infect Dis 2019;69:2019-21. [PMID: 31125399 DOI: 10.1093/cid/ciz295] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Mizusawa M, Carroll KC. Advances and required improvements in methods to diagnosing Clostridioides difficile infections in the healthcare setting. Expert Rev Mol Diagn 2021;21:311-21. [PMID: 33682564 DOI: 10.1080/14737159.2021.1900737] [Reference Citation Analysis]
2 Emberger J, Hitchcock MM, Markley JD. Diagnostic Stewardship Approaches to Clostridioides difficile Infection in the Era of Two-Step Testing: a Shifting Landscape. Curr Treat Options Infect Dis 2020;12:258-74. [DOI: 10.1007/s40506-020-00223-8] [Reference Citation Analysis]
3 Sullivan KV, Gallagher JC, Leekha S, Morgan DJ, Morita K, Rock C, Claeys KC. Use of diagnostic and antimicrobial stewardship practices to improve Clostridioides difficile testing among SHEA Research Network hospitals. Infect Control Hosp Epidemiol 2021;:1-5. [PMID: 34376271 DOI: 10.1017/ice.2021.133] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Sullivan KV. Diagnostic Stewardship in Clinical Microbiology, Essential Partner to Antimicrobial Stewardship. Clinical Chemistry 2022;68:75-82. [DOI: 10.1093/clinchem/hvab206] [Reference Citation Analysis]
5 Dunn AN, Radakovich N, Ancker JS, Donskey CJ, Deshpande A. The Impact of Clinical Decision Support Alerts on Clostridioides difficile Testing: A Systematic Review. Clin Infect Dis 2021;72:987-94. [PMID: 32060501 DOI: 10.1093/cid/ciaa152] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Jenkins TC, Tamma PD. Thinking Beyond the "Core" Antibiotic Stewardship Interventions: Shifting the Onus for Appropriate Antibiotic Use from Stewardship Teams to Prescribing Clinicians. Clin Infect Dis 2021;72:1457-62. [PMID: 32667974 DOI: 10.1093/cid/ciaa1003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Rock C, Maragakis LL. Diagnostic Stewardship for Clostridiodes difficile Testing: From Laxatives to Diarrhea and Beyond. Clin Infect Dis 2020;71:1479-80. [PMID: 31584627 DOI: 10.1093/cid/ciz982] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Karlovich NS, Sata SS, Griffith B, Coop A, Kalu IC, Engemann JJ, Seidelman J, Turner NA, Polage CR, Smith BA, Lewis SS. In pursuit of the holy grail: Improving C. difficile testing appropriateness with iterative electronic health record clinical decision support and targeted test restriction. Infect Control Hosp Epidemiol 2021;:1-8. [PMID: 34085622 DOI: 10.1017/ice.2021.228] [Reference Citation Analysis]
9 Baghdadi JD, Coffey KC, Leekha S, Johnson JK, Diekema DJ, Morgan DJ. Diagnostic Stewardship for Comprehensive Gastrointestinal Pathogen Panel Tests. Curr Infect Dis Rep 2020;22. [DOI: 10.1007/s11908-020-00725-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Tran NN, Mills JP, Zimmerman C, Gandhi TN, Tribble AC, Petty LA, Nagel J, Brancaccio A, Scappaticci G, Patel T, Dillman NO, Regal R, Klein KC, Washer L, Marshall VD, Sweeney J, Rao K, Eschenauer GA. Incorporating preauthorization into antimicrobial stewardship pharmacist workflow reduces Clostridioides difficile and gastrointestinal panel testing. Infect Control Hosp Epidemiol 2020;41:1136-41. [PMID: 32489156 DOI: 10.1017/ice.2020.236] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Nix CD, Messer WB, Hale ML, Lewis JS 2nd, Strasfeld LM. Impact of a Clostridioides Difficile Testing Computerized Clinical Decision Support Tool on an Adult Stem Cell Transplantation and Hematologic Malignancies Unit. Transplant Cell Ther 2021;27:94.e1-5. [PMID: 33045386 DOI: 10.1016/j.bbmt.2020.10.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Marra AR, Alzunitan M, Abosi O, Edmond MB, Street WN, Cromwell JW, Salinas JL. Modest Clostridiodes difficile infection prediction using machine learning models in a tertiary care hospital. Diagn Microbiol Infect Dis 2020;98:115104. [PMID: 32650284 DOI: 10.1016/j.diagmicrobio.2020.115104] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Kang M, Abeles SR, El-Kareh R, Taplitz RA, Nyheim E, Reed SL, Jenkins IH, Seymann GB, Myers FE, Torriani FJ; UCSDH CDI task force. The Effect of Clostridioides difficile Diagnostic Stewardship Interventions on the Diagnosis of Hospital-Onset Clostridioides difficile Infections. Jt Comm J Qual Patient Saf 2020;46:457-63. [PMID: 32576438 DOI: 10.1016/j.jcjq.2020.05.004] [Reference Citation Analysis]
14 Mizusawa M, Carroll KC. The future of Clostridioides difficile diagnostics. Curr Opin Infect Dis 2021;34:483-90. [PMID: 34524199 DOI: 10.1097/QCO.0000000000000754] [Reference Citation Analysis]
15 Liu C, Lan K, Krantz EM, Kim HN, Zier J, Bryson-Cahn C, Chan JD, Jain R, Lynch JB, Pergam SA, Pottinger PS, Sweet A, Whimbey E, Bryan A. Improving Appropriate Diagnosis of Clostridioides difficile Infection Through an Enteric Pathogen Order Set With Computerized Clinical Decision Support: An Interrupted Time Series Analysis. Open Forum Infect Dis 2020;7:ofaa366. [PMID: 33094113 DOI: 10.1093/ofid/ofaa366] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Curren EJ, Lutgring JD, Kabbani S, Diekema DJ, Gitterman S, Lautenbach E, Morgan DJ, Rock C, Salerno RM, McDonald LC. Advancing Diagnostic Stewardship for Healthcare Associated Infections, Antibiotic Resistance, and Sepsis. Clin Infect Dis 2021:ciab672. [PMID: 34346494 DOI: 10.1093/cid/ciab672] [Reference Citation Analysis]
17 Boly FJ, Reske KA, Kwon JH. The Role of Diagnostic Stewardship in Clostridioides difficile Testing: Challenges and Opportunities. Curr Infect Dis Rep 2020;22:7. [PMID: 33762897 DOI: 10.1007/s11908-020-0715-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
18 Rock C, Perlmutter R, Blythe D, Bork J, Claeys K, Cosgrove SE, Dzintars K, Fabre V, Harris AD, Heil E, Hsu YJ, Keller S, Maragakis LL, Milstone AM, Morgan DJ, Dullabh P, Ubri PS, Rotondo C, Brooks R, Leekha S. Impact of Statewide Prevention and Reduction of Clostridioides difficile (SPARC), a Maryland public health-academic collaborative: an evaluation of a quality improvement intervention. BMJ Qual Saf 2021:bmjqs-2021-014014. [PMID: 34887357 DOI: 10.1136/bmjqs-2021-014014] [Reference Citation Analysis]
19 Wang EW, Weekley A, McCarty J, Koo H, Lembcke B, Al Mohajer M. Impact of a division-wide bundle on hospital-acquired Clostridioides difficile cases, antibiotic days of therapy, testing appropriateness, and associated financial costs. Avicenna J Med 2021;11:27-32. [PMID: 33520786 DOI: 10.4103/ajm.ajm_193_19] [Reference Citation Analysis]
20 Madden GR, Enfield KB, Sifri CD. Patient Outcomes With Prevented vs Negative Clostridioides difficile Tests Using a Computerized Clinical Decision Support Tool. Open Forum Infect Dis 2020;7:ofaa094. [PMID: 32328506 DOI: 10.1093/ofid/ofaa094] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Khuvis J, Alsoubani M, Mae Rodday A, Doron S. Impact of Diagnostic Stewardship Interventions on Clostridiodes difficile test ordering practices and results. Clinical Biochemistry 2022. [DOI: 10.1016/j.clinbiochem.2022.03.009] [Reference Citation Analysis]